Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated Pwms and Infectious Risk.Maria Antonella Zingaropoli,Patrizia Pasculli,Matteo Tartaglia,Federica Dominelli,Federica Ciccone,Ambra Taglietti,Valentina Perri,Leonardo Malimpensa,Gina Ferrazzano,Marco Iannetta,Cosmo Del Borgo,Miriam Lichtner,Claudio Maria Mastroianni,Antonella Conte,Maria Rosa CiardiBIOLOGY-BASEL(2023)引用 0|浏览56暂无评分关键词pwMS,ocrelizumab,DMTs,anti-CD20,BAFF,APRIL,CD40L,infectious riskAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要